Antonio Gasbarrini to Liver Neoplasms
This is a "connection" page, showing publications Antonio Gasbarrini has written about Liver Neoplasms.
Connection Strength
1.648
-
Regorafenib: a promising treatment for hepatocellular carcinoma. Expert Opin Pharmacother. 2018 Dec; 19(17):1941-1948.
Score: 0.315
-
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study. Liver Int. 2019 08; 39(8):1478-1489.
Score: 0.083
-
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. J Viral Hepat. 2018 12; 25(12):1493-1500.
Score: 0.078
-
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. Hepatology. 2019 01; 69(1):107-120.
Score: 0.077
-
Metabolic disorders across hepatocellular carcinoma in Italy. Liver Int. 2018 11; 38(11):2028-2039.
Score: 0.077
-
The ten commandments of liver ablation: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2018 06; 22(12):3896-3904.
Score: 0.077
-
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice. Hepatology. 2018 05; 67(5):1784-1796.
Score: 0.076
-
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group. J Gastrointest Surg. 2018 05; 22(5):859-871.
Score: 0.075
-
Sarcopenia in Patients with Advanced Liver Disease. Curr Protein Pept Sci. 2018; 19(7):681-691.
Score: 0.075
-
The ten commandments of chemoembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2018 01; 22(2):372-381.
Score: 0.075
-
The ten commandments of hepatic radioembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2017 Sep; 21(18):4014-4021.
Score: 0.073
-
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study. J Vasc Interv Radiol. 2017 Sep; 28(9):1234-1239.
Score: 0.072
-
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach. World J Gastroenterol. 2017 May 14; 23(18):3195-3204.
Score: 0.071
-
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection. Int J Mol Sci. 2017 May 12; 18(5).
Score: 0.071
-
XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population. Int J Biol Markers. 2017 May 04; 32(2):e190-e194.
Score: 0.071
-
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma. Oncotarget. 2017 Feb 28; 8(9):14408-14415.
Score: 0.070
-
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. J Hepatol. 2017 07; 67(1):65-71.
Score: 0.070
-
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. Aliment Pharmacol Ther. 2017 01; 45(1):160-168.
Score: 0.069
-
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE). Radiol Med. 2013 Jun; 118(4):555-69.
Score: 0.053
-
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? Liver Int. 2018 12; 38(12):2190-2198.
Score: 0.019